Warm Greetings!!!

Welcome to yet another interesting and informative edition of our newsletter!

It has been my privilege to reach you on the 1st & 17th of every month for the last 13 years. Please feel free to share your comments on this edition to enable us to improve constantly. In case you have missed any of our previous issues, you can find them on our website www.jagograhakjago.com or in the News Archive section of every issue of The Prescription. You can also look us up on Facebook.

Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief

"If someone has a stroke today, they think it is because of the Covid vaccine. ICMR has done a detailed study that the (Covid) vaccine is not responsible for heart attacks."

Dr. Mansukh Mandaviya
Minister of Health and Family Welfare, Govt of India

Feb28,2024: Supreme Court criticizes Centre for not implementing Clinical Establishment Rules for standard rates, warns of implementing CGHS-prescribed rates if states don't comply. Read More...

Mar 11,2024: New Delhi: Scientists have discovered a new class of antiviral drugs with the potential to prevent or treat COVID-19 infections in a future outbreak. In a study published in the journal Nature, the researchers show that SARS-CoV-2 – the virus that causes COVID-19 – activates a pathway in cells that stops the production of peroxisomes and interferon, both key parts of the normal immune response. Read More...

Mar 14,2024: We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical industry and medical professionals," Indian Drug Manufacturers' Association (IDMA) national president Viranchi Shah said. Read More...

Mar 12,2024: AstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca will retain the intellectual property rights to Symbicort and continue as the marketing authorization holder. Symbicort, a top-selling product globally for AstraZeneca, recorded sales of around $2.4 billion in 2023. Read More...

Mar 15,2024: Prices of essential medicines including painkillers, antibiotics and anti-infectives are set to see a minuscule increase from April 1. Read More...

Mar 11,2024: A division bench of MP high court recalled its order passed on November 28, 2023, on a contempt petition in which it had held the additional chief secretary, health & gas relief, Mohd Suleman and two officials of National Informatics Centre (NIC) Read More...

Mar 13,2024: The company said it plans to conduct two separate trials testing Gardasil 9 in men and women 16-26 years old to examine whether a single dose of the vaccine provides comparable long-term protection when compared with the approved three-dose regimen. Read More...

Mar 09,2024: A man diagnosed with aggressive brain cancer has made a remarkable recovery after participating in a groundbreaking clinical trial. Ben Trotman, given a few months to live, underwent immunotherapy treatment that utilized his own immune system to combat the tumor. Read More...

Mar 07,2024: A German man who deliberately got vaccinated for Covid-19 a whopping 217 times did not report any side effects from his many jabs, according to researchers studying possibly the "most vaccinated person in history". The man reported that he never had any vaccine-related side effects from any of the 217 jabs. Read More...

Mar 13,2024: The Enforcement Directorate (ED) has filed a Prosecution Complaint (PC) on 08-01-2024 under the provisions of the Prevention of Money Laundering Act (PMLA), 2002 against Amit Katyal, Rabri Devi, Misha Bharti, Hema Yadav, Hridyanand Chaudhary and two companies viz. AK Infosystems Private Limited, AB Exports Pvt. Ltd. before the Rouse Avenue court. Read More...

Mar 14,2024: Interacting with ETHealthworld, Namita Thapar, Whole-time Director, Emcure Pharmaceuticals, shared that the product has been well received by doctors and patients, which prompted the company to go ahead and bring their product into the market. Read More...

Mar 14,2024: Ionis Pharmaceuticals said on Wednesday its experimental drug to treat a type of fatty liver disease met the main goal of reducing inflammation of the critical organ in a mid-stage trial. Read More...

Mar 14,2024: Regulatory approval for the therapies as earlier treatments could expand their use to a larger subset of blood cancer patients who are less sick than those treated with multiple therapies. Read More...

 

Mar 13,2024: It would require a national mission, certain goals and targets to be set, investment, partnerships and collaborations, Swaminathan said. India is in the best position to do this as it has all of the above ingredients, only everyone needs to come together and set a goal to make infectious diseases history, she added. "Any infectious disease that has been eliminated has been done through vaccines. Read More...

NEW DELHI: As Covid-19 cases rise in the country, the network of laboratories set up to monitor genomic variations of the coronavirus in India will hold a meeting on Friday. Read More...

Stem cells and their derivatives fall under definition of ‘Drug’ as per the Drugs and Cosmetics
Act 1940, and are categorized as ‘Investigational New Drug (IND)’ or ‘Investigational New Entity
(INE)’ when used for clinical application. Hence clinical trials are a must before these can be applied for any unproven applications and the principles of bioethics and regulation must be followed accordingly before initiating clinical
trials.

Mar 11,2024: The study, published in the journal Science Advances, shows that the biomarker used in the test accurately predicted when the study volunteers had been awake for over 24 hours under controlled laboratory conditions. Read More...

Mar 13,2024: The study, conducted between January 2019 and June 2023, followed 183 ESRD patients referred for bariatric surgery, with 36 undergoing weight loss surgery and 10 subsequently receiving kidney transplants. Read More...

Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
www.jagograhakjago.com
Disclaimer: Our newsletter endeavors to compile patient safety information from various sources. PSAIIF may not be held responsible for any article published in The Prescription.

We request our esteemed readers to write to us at bejonmisra@jagograhakjago.com with your feedback and suggestions on what you would like us to feature in the newsletter.